ESC 365 - C-type natriuretic peptide improves left ventricular diastolic dysfunction and ischemia/reperfusion injury-associated ventricular arrhythmias

ESC Premium Access

C-type natriuretic peptide improves left ventricular diastolic dysfunction and ischemia/reperfusion injury-associated ventricular arrhythmias

Session: Poster Session 4 - Chronic heart failure – pathophysiology and mechanisms

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Professor T. Soeki (Tokushima, JP)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Takeshi Soeki

Tokushima University, Tokushima (Japan)

0 follower

21 more presentations in this session

Effects of mineralocorticoid receptor antagonists on diastolic function and exercise capacity in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials

Speaker: Associate Professor H. Fukuta (Nagoya, JP)

Prognostic value of soluble ST2 biomarker in heart failure patients with preserved ejection fraction

Speaker: Doctor K. Kopeva (Tomsk, RU)

Astragaloside IV reduces cardiac oxidation and improves left ventricular diastolic dysfunction

Speaker: Doctor Q. Wang (Lanzhou, CN)

Long non coding RNA levels in hypertensive patients with heart failure with preserved ejection fraction and their relation to their functional capacity

Speaker: Associate Professor M. Marketou (Heraklion, GR)

Morphological and functional changes in cardiovascular system in heart failure with preserved ejection fraction.

Speaker: Doctor M. Kurkina (Moscow, RU)

Access the full session

Poster Session 4 - Chronic heart failure – pathophysiology and mechanisms

Speakers: Professor T. Soeki, Associate Professor H. Fukuta, Doctor K. Kopeva, Doctor Q. Wang, Associate Professor M. Marketou...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources